|
NL291628A
(https=)
|
1962-04-17 |
|
|
|
|
US4022901A
(en)
|
1975-03-05 |
1977-05-10 |
E. R. Squibb & Sons, Inc. |
3-Pyridinyl-5-isothiocyanophenyl oxadiazoles
|
|
US4016170A
(en)
|
1975-07-28 |
1977-04-05 |
Sandoz, Inc. |
Oxadiazolyl benzamides
|
|
US4166732A
(en)
|
1977-05-12 |
1979-09-04 |
Monsanto Company |
Oxadiazol-5-yl-benzoates
|
|
US4135910A
(en)
|
1977-05-12 |
1979-01-23 |
Monsanto Company |
Oxadiazol-3-yl-benzoates as plant growth regulants
|
|
US4210762A
(en)
|
1978-08-17 |
1980-07-01 |
Monsanto Company |
2[5-(3-Trifluoromethylphenyl)-1,3,4-oxadiazol-2-yl] benzoates
|
|
US4268299A
(en)
|
1978-08-17 |
1981-05-19 |
Monsanto Company |
Method and composition for plant growth regulation containing trifluoromethyl 1,3,4 oxadiazol benzoates
|
|
US5484944A
(en)
|
1993-10-27 |
1996-01-16 |
Neurogen Corporation |
Certain fused pyrrolecarboxanilides and their use as GABA brain receptor ligands
|
|
TW343965B
(en)
|
1994-03-30 |
1998-11-01 |
Hoffmann La Roche |
Novel mono- and bicyclic DNA gyrase inhibitors
|
|
US6071700A
(en)
|
1995-01-20 |
2000-06-06 |
University Of Massachusetts |
Heterologous polypeptide production in the absence of nonsense-mediated MRNA decay functions
|
|
CZ66498A3
(cs)
|
1995-09-07 |
1998-07-15 |
Novartis Ag |
Substituované fosfinové kyseliny, způsoby jejich přípravy, farmaceutický prostředek, který je obsahuje, a jejich použití
|
|
WO1997041105A1
(en)
|
1996-04-26 |
1997-11-06 |
Nippon Soda Co., Ltd. |
Novel heterocycle-substituted benzene derivatives and herbicides
|
|
DE19620041A1
(de)
|
1996-05-17 |
1998-01-29 |
Merck Patent Gmbh |
Adhäsionsrezeptor-Antagonisten
|
|
WO1997046556A1
(en)
|
1996-06-07 |
1997-12-11 |
Merck & Co., Inc. |
OXADIAZOLE BENZENESULFONAMIDES AS SELECTIVE β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY
|
|
US6034106A
(en)
|
1996-06-07 |
2000-03-07 |
Merck & Co., Inc. |
Oxadiazole benzenesulfonamides as selective β3 Agonist for the treatment of Diabetes and Obesity
|
|
DE19626318A1
(de)
|
1996-07-01 |
1998-01-08 |
Basf Ag |
Farbstoffmischungen, enthaltend Polyazofarbstoffe
|
|
ZA98371B
(en)
|
1997-01-31 |
1999-07-16 |
Du Pont |
Genetically transformed plants demonstrating resistance to porphyrinogen biosynthesis-inhibiting herbicides.
|
|
US6180648B1
(en)
|
1997-04-07 |
2001-01-30 |
Biostream Therapeutics, Inc. |
Analogs of cocaine
|
|
US6004933A
(en)
|
1997-04-25 |
1999-12-21 |
Cortech Inc. |
Cysteine protease inhibitors
|
|
AU9647998A
(en)
|
1997-10-27 |
1999-05-17 |
Nippon Soda Co., Ltd. |
Novel benzoylpyrazole derivatives and herbicides
|
|
AU750369B2
(en)
|
1998-04-23 |
2002-07-18 |
Cortech, Inc. |
Cysteine protease inhibitors
|
|
WO2000021951A1
(en)
|
1998-10-08 |
2000-04-20 |
Smithkline Beecham Plc |
Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
|
|
CA2346396C
(en)
|
1998-10-09 |
2009-04-28 |
Janssen Pharmaceutica N.V. |
4,5-dihydro-isoxazole derivatives and their pharmaceutical use
|
|
EP1126833A4
(en)
|
1998-10-29 |
2004-09-08 |
Trega Biosciences Inc |
OXADIAZOLE, THIADIAZOLE AND TRIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES CONTAINING THESE DERIVATIVES
|
|
KR100630986B1
(ko)
|
1998-12-23 |
2006-10-09 |
스미스클라인 비참 코포레이션 |
프로테아제 억제제
|
|
AU3196300A
(en)
|
1999-03-26 |
2000-10-16 |
Shionogi & Co., Ltd. |
Carbocyclic sulfonamide derivatives
|
|
WO2000058278A1
(fr)
|
1999-03-26 |
2000-10-05 |
Shionogi & Co., Ltd. |
Derives d'acides amines $g(b)
|
|
WO2000058304A1
(en)
|
1999-03-26 |
2000-10-05 |
Shionogi & Co., Ltd. |
Heterocyclic sulfonamide derivatives
|
|
DE60023492T2
(de)
|
1999-05-17 |
2006-07-20 |
Novo Nordisk A/S |
Glucagon antagonisten/inverse agonisten
|
|
UA71971C2
(en)
|
1999-06-04 |
2005-01-17 |
Agoron Pharmaceuticals Inc |
Diaminothiazoles, composition based thereon, a method for modulation of protein kinases activity, a method for the treatment of diseases mediated by protein kinases
|
|
JP2001247569A
(ja)
|
1999-08-12 |
2001-09-11 |
Japan Tobacco Inc |
ピロリジン誘導体又はピペリジン誘導体及びその医薬用途
|
|
US6660753B2
(en)
|
1999-08-19 |
2003-12-09 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
WO2001066534A2
(en)
|
2000-03-09 |
2001-09-13 |
Abbott Laboratories |
Cyclic and bicyclic diamino histamine-3 receptor antagonists
|
|
US6498151B2
(en)
|
2000-03-22 |
2002-12-24 |
Merck Frosst Canada & Co. |
Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors
|
|
WO2001083464A1
(en)
|
2000-04-21 |
2001-11-08 |
Shionogi & Co., Ltd. |
Oxadiazole derivatives having therapeutic or preventive efficacies against glomerular disorders
|
|
GB0011089D0
(en)
|
2000-05-08 |
2000-06-28 |
Black James Foundation |
Gastrin and cholecystokinin receptor ligands (11)
|
|
OA12274A
(en)
|
2000-05-22 |
2006-05-09 |
Aventis Pharma Inc |
Arylmethylamine derivatives for use as tryptase inhibitors.
|
|
JP2002105073A
(ja)
|
2000-09-27 |
2002-04-10 |
Shionogi & Co Ltd |
新規マトリックスメタロプロテアーゼ阻害剤
|
|
AUPR362001A0
(en)
|
2001-03-08 |
2001-04-05 |
Fujisawa Pharmaceutical Co., Ltd. |
New compound
|
|
CA2342432A1
(en)
|
2001-03-28 |
2002-09-28 |
Christopher Norbert Johnson |
Novel compound
|
|
GB0108102D0
(en)
|
2001-03-30 |
2001-05-23 |
Pfizer Ltd |
Compounds
|
|
RU2003133750A
(ru)
|
2001-04-19 |
2005-05-10 |
Байер АГ (DE) |
Арилсульфонамиды в качестве антивирусных агентов
|
|
JP2005504014A
(ja)
|
2001-06-08 |
2005-02-10 |
サイトビア インコーポレイテッド |
カスパーゼの活性化因子およびアポトーシスの誘導因子としての置換された３−アリール−５−アリール−［１，２，４］−オキサジアゾール類および類似体、並びにその使用法
|
|
EP1405636A4
(en)
|
2001-06-26 |
2009-04-15 |
Takeda Pharmaceutical |
FUNCTIONAL REGULATOR FOR RETINOID RELATIVE RECEPTOR
|
|
JP2003081832A
(ja)
|
2001-06-26 |
2003-03-19 |
Takeda Chem Ind Ltd |
レチノイド関連受容体機能調節剤
|
|
GB0115862D0
(en)
|
2001-06-28 |
2001-08-22 |
Smithkline Beecham Plc |
Compounds
|
|
MY151199A
(en)
|
2001-11-02 |
2014-04-30 |
Rigel Pharmaceuticals Inc |
Substituted diphenyl heterocycles useful for treating hcv infection
|
|
TW200424183A
(en)
|
2002-08-09 |
2004-11-16 |
Nps Pharma Inc |
New compounds
|
|
US7074809B2
(en)
|
2002-08-09 |
2006-07-11 |
Astrazeneca Ab |
Compounds
|
|
GB0303503D0
(en)
|
2003-02-14 |
2003-03-19 |
Novartis Ag |
Organic compounds
|
|
JP2006521344A
(ja)
|
2003-03-28 |
2006-09-21 |
ファイザー・プロダクツ・インク |
アテローム性動脈硬化症および肥満の治療のためのｃｅｔｐ阻害剤としての１，２，４−置換１，２，３，４−テトラヒドロ−および１，２−ジヒドロ−キノリンおよび１，２，３，４−テトラヒドロ−キノキサリン誘導体
|
|
HUE047569T2
(hu)
*
|
2003-04-11 |
2020-04-28 |
Ptc Therapeutics Inc |
1,2,4-oxadiazol-benzoesav vegyület és nonszensz szupresszióra történõ alkalmazása
|
|
WO2004110351A2
(en)
|
2003-05-14 |
2004-12-23 |
Anadys Pharmaceuticals, Inc. |
Heterocyclic compounds for treating hepatitis c virus
|
|
JP5255183B2
(ja)
*
|
2003-09-04 |
2013-08-07 |
ウォックハート リミテッド |
ベンゾキノリジン−２−カルボン酸アルギニン塩四水和物
|
|
GB0321827D0
(en)
*
|
2003-09-18 |
2003-10-15 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
WO2005060961A2
(en)
|
2003-12-18 |
2005-07-07 |
Astrazeneca Ab |
Treatment of transient lower esophageal sphincter relaxations (tlesrs) and gastro-esophageal reflux disease (gerd)
|
|
US7745630B2
(en)
|
2003-12-22 |
2010-06-29 |
Justin Stephen Bryans |
Triazolyl piperidine arginine vasopressin receptor modulators
|
|
WO2005077373A2
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
|
WO2005097096A1
(en)
*
|
2004-03-31 |
2005-10-20 |
Pharmacia & Upjohn Company Llc |
A phenyl acetic acid cyclooxygenase-2 inhibitor for the treatment of ocular disorders
|
|
EP2402323A3
(en)
|
2004-10-13 |
2012-05-30 |
PTC Therapeutics, Inc. |
Pyrazole or triazole compounds and their use for the manufacture of a medicament for treating somatic mutation-related diseases
|
|
PT2402002T
(pt)
*
|
2005-04-08 |
2018-10-08 |
Ptc Therapeutics Inc |
Composições de 1,2,4-oxadiazole oralmente activo para terapia de supressão de mutações nonsense
|
|
CN101193632A
(zh)
*
|
2005-04-08 |
2008-06-04 |
Ptc医疗公司 |
用于无义突变抑制治疗的口服活性1,2,4-噁二唑组合物
|
|
RU2462246C2
(ru)
*
|
2006-03-30 |
2012-09-27 |
ПиТиСи ТЕРАПЬЮТИКС, ИНК. |
Способы получения функционального белка из днк, имеющей нонсенс-мутацию, и лечения нарушений, ассоциированных с ней
|
|
WO2007123848A2
(en)
|
2006-04-19 |
2007-11-01 |
Brown University |
Therapeutic compositions containing modified class i slrp proteins
|
|
MX2009002439A
(es)
|
2006-09-08 |
2009-03-27 |
Ptc Therapeutics Inc |
Procesos para la preparacion de acidos 1,2,4-oxadiazolbenzoicos.
|
|
PL2076501T3
(pl)
|
2006-09-25 |
2016-06-30 |
Ptc Therapeutics Inc |
Postacie krystaliczne kwasu 3-[5-(2-fluorofenylo)[1,2,4]oksadiazol-3-ilo]-benzoesowego
|
|
US8101641B2
(en)
|
2006-09-25 |
2012-01-24 |
Ptc Therapeutics, Inc. |
Hydroxylated 1,2,4-oxadiazole benzoic acid compounds and compositions thereof
|
|
RS54025B1
(sr)
|
2006-10-12 |
2015-10-30 |
Ptc Therapeutics Inc. |
Postupci doziranja oralno aktivnog 1,2,4-oksadiazola za supresionu terapiju nonsens mutacije
|
|
WO2008127364A2
(en)
|
2006-10-13 |
2008-10-23 |
Myriad Genetics, Inc. |
Antiviral compounds and use thereof
|
|
US20110177999A1
(en)
|
2007-08-09 |
2011-07-21 |
Vertex Pharmaceuticals Incorporated |
Therapeutic Combinations Useful in Treating CFTR Related Diseases
|
|
MX2010003612A
(es)
|
2007-10-04 |
2010-04-30 |
Merck Serono Sa |
Derivados de oxadiazol.
|
|
ES2639852T3
(es)
|
2007-10-26 |
2017-10-30 |
Academisch Ziekenhuis Leiden |
Medios y métodos para contrarrestar los trastornos musculares
|
|
US8852568B2
(en)
|
2007-12-17 |
2014-10-07 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and preventing skeletal muscle deficiencies
|
|
EP2276763A1
(en)
|
2008-03-19 |
2011-01-26 |
OSI Pharmaceuticals, Inc. |
Mtor inhibitor salt forms
|
|
CN102076670B
(zh)
|
2008-06-24 |
2013-05-22 |
Irm责任有限公司 |
调节g蛋白偶联受体的化合物和方法
|
|
US8063227B2
(en)
|
2008-07-14 |
2011-11-22 |
Ferrokin Biosciences, Inc. |
Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents
|
|
KR101959873B1
(ko)
|
2008-10-07 |
2019-03-19 |
랩터 파마슈티컬스 인코포레이티드 |
약동학 개선을 위한 에어로졸 플루오로퀴놀론 제형
|
|
RU2398770C1
(ru)
|
2009-03-27 |
2010-09-10 |
Учреждение Российской академии наук Институт молекулярной генетики РАН (ИМГ РАН) |
Меченная тритием 3-[5-(2-фторфенил)-1,2,4-оксадиазол-3-ил]бензойная кислота
|
|
US20120289476A1
(en)
|
2009-12-11 |
2012-11-15 |
Jay Allan Barth |
Methods for treating methylmalonic acidemia
|
|
EP2559443A1
(en)
*
|
2011-08-16 |
2013-02-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the treatment of an ocular disease in a subject
|
|
WO2014153643A1
(en)
*
|
2013-03-26 |
2014-10-02 |
The University Of British Columbia |
Compositions and methods for use thereof in the treatment of aniridia
|
|
KR102497273B1
(ko)
*
|
2014-03-06 |
2023-02-07 |
피티씨 테라퓨틱스, 인크. |
1,2,4-옥사디아졸 벤조산의 약학 조성물 및 염
|
|
US20170196842A1
(en)
|
2014-06-06 |
2017-07-13 |
Ptc Therapeutics, Inc. |
Methods of treatment using a 1,2,4-oxadiazole benzoic acid
|